Saplith to Neurodegenative Disease SupportEnglish • 2 years agoFDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patientswww.wsj.comexternal-linkmessage-square7fedilinkarrow-up16arrow-down10
arrow-up16arrow-down1external-linkFDA Approves Leqembi, Extending Alzheimer’s Treatment to More Patientswww.wsj.comSaplith to Neurodegenative Disease SupportEnglish • 2 years agomessage-square7fedilink
minus-square108beadsMlinkfedilinkEnglish3•edit-22 years agoThank you for posting this! Sadly, it wouldn’t work for us as Beloved Dementor’s various health providers twaddled around and refused to consider Alzheimer’s for too long. But it is good news (albeit with some risks) for those in early stages.
minus-square@ZenGrammyMlinkEnglish3•2 years agoThat is so shitty. Those are also some serious risks to consider, though. I don’t know if I’d do it if I were a person with early Alzheimer’s.
minus-squareSaplithOPlinkfedilinkEnglish2•2 years agoThat really sucks. Hopefully there will eventually be something to help in a useful time frame.
Thank you for posting this! Sadly, it wouldn’t work for us as Beloved Dementor’s various health providers twaddled around and refused to consider Alzheimer’s for too long. But it is good news (albeit with some risks) for those in early stages.
That is so shitty. Those are also some serious risks to consider, though. I don’t know if I’d do it if I were a person with early Alzheimer’s.
That really sucks. Hopefully there will eventually be something to help in a useful time frame.